Side-by-side comparison of AI visibility scores, market position, and capabilities
Credit rating and analytics duopolist with $7.1B FY2024 revenue; Berkshire Hathaway ~12% stake; 50%+ MIS operating margins; generative AI tools for credit analysis; RMS catastrophe risk acquisition.
Moody's Corporation is a global integrated risk assessment firm and the parent of Moody's Investors Service (MIS), one of the world's two largest credit rating agencies, and Moody's Analytics (MA), a leading provider of financial intelligence and analytical tools, founded in 1909 by John Moody in New York City, where it remains headquartered and trades on NYSE (MCO). The company generated approximately $7.1 billion in revenues for FY2024 under CEO Rob Fauber, with Moody's Investors Service benefiting from elevated debt issuance volumes driven by corporate refinancing activity, CLO formation, and infrastructure financing, while Moody's Analytics delivered high single-digit growth from recurring subscription revenues in its banking, insurance, and corporate risk management software platforms. Berkshire Hathaway owns approximately 12% of Moody's shares, a long-term holding reflecting Warren Buffett's appreciation for the company's near-duopoly pricing power in credit ratings.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.